7 results on '"Poy Lorenzo YS"'
Search Results
2. Detection, management, and prevention of diabetes-related foot disease in the Australian context.
- Author
-
McNeil S, Waller K, Poy Lorenzo YS, Mateevici OC, Telianidis S, Qi S, Churilov I, MacIsaac RJ, and Galligan A
- Abstract
Diabetes-related foot disease (DFD) is a widely feared complication among people who live with diabetes. In Australia and globally, rates of disability, cardio-vascular disease, lower extremity amputation, and mortality are significantly increased in patients with DFD. In order to understand and prevent these outcomes, we analyse the common pathogenetic processes of neuropathy, arterial disease, and infection. The review then summarises important management considerations through the interdisciplinary lens. Using Australian and international guidelines, we offer a stepwise, evidence-based practical approach to the care of patients with DFD., Competing Interests: Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article., (©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
3. Patterns and Predictors of Outpatient Antibiotic Dispensation Following Total Hip and Knee Arthroplasty.
- Author
-
Naufal E, Shadbolt C, Elsiwy Y, Thuraisingam S, Poy Lorenzo YS, Darby J, Babazadeh S, Choong PFM, Dowsey MM, and Stevens JM
- Subjects
- Anti-Bacterial Agents therapeutic use, Australia epidemiology, Cross-Sectional Studies, Humans, Outpatients, Postoperative Complications etiology, Risk Factors, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Knee adverse effects
- Abstract
Background: This study aimed to evaluate the month-to-month prevalence of antibiotic dispensation in the 12 months before and after total knee arthroplasty (TKA) and total hip arthroplasty (THA) and to identify factors associated with antibiotic dispensation in the month immediately following the surgical procedure., Methods: In total, 4,115 THAs and TKAs performed between April 2013 and June 2019 from a state-wide arthroplasty referral center were analyzed. A cross-sectional study used data from an institutional arthroplasty registry, which was linked probabilistically to administrative dispensing data from the Australian Pharmaceutical Benefits Scheme. Multivariable logistic regression was carried out to identify patient and surgical risk factors for oral antibiotic dispensation., Results: Oral antibiotics were dispensed in 18.3% of patients following primary TKA and 12.0% of patients following THA in the 30 days following discharge. During the year after discharge, 66.7% of TKA patients and 58.2% of THA patients were dispensed an antibiotic at some point. Patients with poor preoperative health status were more likely to have antibiotics dispensed in the month following THA or TKA. Older age, undergoing TKA rather than THA, obesity, inflammatory arthritis, and experiencing an in-hospital wound-related or other infectious complications were associated with increased antibiotic dispensation in the 30 days following discharge., Conclusion: A high rate of antibiotic dispensation in the 30 days following THA and TKA has been observed. Although resource constraints may limit routine wound review for all patients by a surgeon, a select cohort may benefit from timely specialist review postoperatively. Several risk factors identified in this study may aid in identifying appropriate candidates for such changes to follow-up care., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
4. Mecillinam susceptibility in Victorian third generation cephalosporin-nonsusceptible Escherichia coli urinary isolates.
- Author
-
Olenski M, Jardine D, Poy Lorenzo YS, and Crowe A
- Subjects
- Drug Resistance, Bacterial, Escherichia coli Infections drug therapy, Female, Humans, Urinary Tract Infections drug therapy, Amdinocillin pharmacology, Anti-Bacterial Agents pharmacology, Cephalosporins pharmacology, Escherichia coli drug effects, Escherichia coli Infections microbiology, Urinary Tract Infections microbiology
- Published
- 2021
- Full Text
- View/download PDF
5. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study.
- Author
-
Cronin KM, Poy Lorenzo YS, Olenski ME, Bloch AE, Visvanathan K, Waters MJ, and Buising KL
- Subjects
- Adult, Aged, Aged, 80 and over, Australia epidemiology, Carrier State microbiology, Case-Control Studies, Enterobacteriaceae isolation & purification, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Young Adult, Bacterial Proteins metabolism, Carrier State epidemiology, Cross Infection epidemiology, Enterobacteriaceae enzymology, Enterobacteriaceae Infections epidemiology, beta-Lactamases metabolism
- Abstract
Background: Reports of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) in Australia were previously uncommon, with cases imported sporadically by travellers from higher prevalence countries., Aim: The study institution reported the first outbreak of KPC-Kp in Australia. The aim of this study was to identify risk factors for KPC-Kp colonization and infection using a matched case-control study., Methods: The study included all hospitalized patients with KPC-Kp colonization or infection from January 2012 to September 2015., Findings: Thirty-four cases of KPC-producing Enterobacteriaceae (including 31 KPC-Kp cases) were matched with 136 controls. Variables associated with KPC-Kp acquisition included: length of hospital stay >28 days in the past 12 months, prior vancomycin-resistant enterococci (VRE) colonization, central venous catheter (CVC), gastrointestinal disease and invasive procedures. Exposure to broad-spectrum antibiotics was also found to be a significant risk factor. In the multi-variate analysis, three factors independently associated with KPC-Kp acquisition were length of hospital stay >28 days in the past 12 months [odds ratio (OR) 23.6, 95% confidence interval (CI) 4.9-113.3], presence of a CVC (OR 15.4, 95% CI 2.7-86.9), and prior VRE colonization (OR 6.0, 95% CI 1.6-23.2). Very few patients had a history of overseas travel., Conclusion: This study demonstrates that patients with prolonged hospital exposure are more likely to acquire KPC-Kp in the setting of a local outbreak, and suggests that risk factors for KPC-Kp acquisition may be shared with those for VRE colonization. Local screening strategies targeting overseas travellers would likely miss many cases. The results of this study will help to inform screening policies for carbapenemase-producing Enterobacteriaceae., (Copyright © 2017 The Healthcare Infection Society. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
6. Carbapenemase-producing Klebsiella pneumoniae: a major clinical challenge.
- Author
-
Mandrawa CL, Cronin K, Buising KL, Poy Lorenzo YS, Waters MJ, and Jeremiah CJ
- Subjects
- Azabicyclo Compounds therapeutic use, Carbapenems pharmacology, Ceftazidime, Humans, Klebsiella Infections drug therapy, Klebsiella pneumoniae drug effects, Male, Metronidazole therapeutic use, Middle Aged, Pancreatic Diseases microbiology, Teicoplanin therapeutic use, Bacterial Proteins biosynthesis, Drug Resistance, Bacterial, Klebsiella pneumoniae enzymology, beta-Lactamases biosynthesis
- Published
- 2016
- Full Text
- View/download PDF
7. Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: an early Australian hospital experience.
- Author
-
Chang LW, Buising KL, Jeremiah CJ, Cronin K, Poy Lorenzo YS, Howden BP, Kwong J, Cocks J, Blood A, Greenough J, and Waters MJ
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Australia epidemiology, Carbapenems therapeutic use, Disease Outbreaks, Female, Humans, Infection Control, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Young Adult, Cross Infection drug therapy, Hospital Mortality, Klebsiella Infections drug therapy, Klebsiella pneumoniae isolation & purification, beta-Lactam Resistance genetics, beta-Lactamases genetics
- Abstract
Background: Carbapenems are traditionally reserved as the last line of defence for treatment of serious infections with multiresistant Gram-negative bacilli. Reports of Klebsiella pneumoniae carbapenemase (KPC)-producing organisms have been emerging globally, but rare in Australasia to date. We describe an outbreak of KPC-2 producing K. pneumoniae at an Australian hospital., Methods: After initial detection in October 2012, a retrospective review of patients with meropenem-resistant K. pneumoniae to June 2012, and ongoing prospective surveillance, was undertaken. Included patients were admitted to the hospital after June 2012 and had meropenem-resistant K. pneumoniae isolated from any site. Available isolates underwent detection of the KPC-2 gene by polymerase chain reaction and molecular typing was performed to determine genetic relatedness between isolates. Point-prevalence screening was performed on selected wards to detect asymptomatic carriage. Infection control procedures were implemented to contain the outbreak., Results: Ten cases were identified in the initial cluster. Eight were localised to a single inpatient ward. Point-prevalence screening revealed one extra case. After temporary containment, re-emergence of KPC-producing isolates was observed post October 2013 with 18 further cases identified. Four K. pneumoniae isolates in the 2012 cluster and 16 from the 2013-2014 cluster were referred for further testing. All carried the KPC-2 beta-lactamase gene. The 2012 isolates were genetically similar to the 2014 isolates., Conclusion: KPC-2 mediated resistance is an emerging threat in Australia. The re-emergence of KPC despite initial containment emphasises the need for constant vigilance in the microbiology laboratory and ongoing maintenance of infection control and antimicrobial stewardship activity., (© 2015 Royal Australasian College of Physicians.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.